FAQ

MannanPRO® FAQ

MannanPRO® is a ≥ 90 %-purity acemannan extract isolated from the inner fillet of Aloe barbadensis via Dazzeon’s patented solvent-precipitation process.

Internal & published data show non-acemannan polysaccharides dampen bio-activity. Removing them boosts cell-proliferation, barrier repair and antioxidant scores by 20–40 % at the same dose. No one in the world can achieve this purity, by a long shot!

MannanPRO® can be applied to a wide range of B2C consumer product lines as your X factor. Depending on the product, we recommend different formulations, for example:
Cosmetics — 0.02–0.12 % w/w (gives 10–30 mg active acemannan per unit).

Nutra gel-drink / capsule — 11–33 mg MannanPRO® (10–30 mg active) per serving.

• Gastro-mucosal protection (Shay’s ulcer model)• Prebiotic modulation (SHIME®; ↑ propionate, ↓ opportunistic taxa)• Skin barrier & antioxidant / anti-inflammatory effects (HaCaT, UV, ROS assays), and many many more

MannanPRO® has a series of recognitions, including INCI No. 39405 (cosmetic use) • ISO 22000 / HACCP plant; GMP upgrade in progress (2026 Q2)• Completed irritation, sensitization, mutagenicity screens—all negative, as well as being a TFDA positive list raw material, since it contains no aloin

Generic extracts are 5–20 % acemannan polysaccharide. MannanPRO® delivers 9× more active acemannan, eliminates laxative anthraquinones, and meets pharmacopeial requirements.

• Freeze-dried powder • Custom capsule, gel-drink, sheet-mask essence prototypes.

Due to years of optimization, MannanPRO’s cost is well within expectations for a typical consumer product raw material, even though its anything but typical! Please reach out to us for a full quotation!

Yes. It is water-soluble, non-ionic, and shows no precipitation with common actives; it can even synergize with peptides by enhancing skin barrier and moisture.

Email info@dazzeonbiotech.com with your intended application. We provide a MannanPRO® Experience Kit (500-unit raw material, SDS, spec sheet) and JP/EN/CH pitch decks for nutraceutical, cosmetic, and forthcoming pharma use.

Dazztex® FAQ

Dazztex is a proprietary textile that embeds finely ground, high-grade mineral nanoparticles deep inside every fibre. These minerals behave as “black-body” emitters, releasing far-infrared radiation (FIR) with an average emissivity of 0.94 at room temperature—well above ordinary FIR fabrics (0.80–0.88).

When the 4–14 μm FIR emitted by Dazztex® is absorbed by tissue, it penetrates 6–7 cm below the skin, gently raising local temperature by 3–4 °C. This accelerates micro-vascular flow, boosts blood oxygen ( +2 %), and helps shuttle metabolic by-products such as lactic acid away from fatigued or inflamed areas.

Users commonly report warmer extremities, faster muscle recovery after exercise, reduced stiffness, and deeper sleep quality—outcomes consistent with published FIR literature and the clinical effects listed in multiple independent studies (e.g., improved circulation, pain relief, autonomic-nervous stability).

No. Conventional heat pads rely on external electricity to create a thermal effect on the skin surface. Dazztex® converts your own body heat into FIR “bio-energy,” delivering non-electric, non-contact photobiomodulation without hot-spot risk or electromagnetic fields

• Higher emissivity (0.94 vs. ≤ 0.88) • Deeper warmth (+3–4 °C vs. ≤ 1 °C) • No plug-in (safe for prolonged contact) • Both fabric faces are active thanks to a double-sided nanopowder infusion.

Yes. The mineral-infused fibres can be laminated into localized patches or wraps. These drug-free, odour-less patches are ideal for menstrual discomfort, neck/shoulder strain, or sport-related micro-injuries—delivering the same FIR bio-energy exactly where it is needed.

Independent laboratory testing shows the emissivity remains ≥ 0.94 after 30 machine-wash and tumble-dry cycles. Simply wash below 30 °C and dry below 60 °C to maintain performance.

The fabric is SGS-certified non-toxic and non-electric. Typical contraindications for FIR therapy apply (e.g., acute infections, active bleeding disorders, implanted pacemakers). If you are pregnant, have cancer, or any of the conditions listed by regulatory guidance, consult a physician before use.